Trials / Unknown
UnknownNCT05495113
The Efficacy and Safety of tDCS in Patients With Mild Dementia
In a Patient With Mild Dementia, Improvement of Cognitive Function Using YMS-201B, To Evaluate the Effectiveness and Safety, Randomized, Double-blinded, Sham Control Comparison, Confirmatory
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 118 (estimated)
- Sponsor
- Ybrain Inc. · Industry
- Sex
- All
- Age
- 55 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the effectiveness and safety of improving Mild Dementia by applying tDCS for 26 weeks to patients with Mild Dementia.
Detailed description
Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5\~7 times a week and they were evaluated every 26weeks through questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | YMS-201B (Device: Mind STIM) | transcranial Direct Current Stimulation (tDCS) 2mA for 30 min; 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC) |
| DEVICE | Sham stimulation using YMS-201B | Sham stimulation; only 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC) |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2022-09-30
- Completion
- 2022-12-30
- First posted
- 2022-08-10
- Last updated
- 2022-09-28
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05495113. Inclusion in this directory is not an endorsement.